Biologics Manufacturing Asia 2016

Biomanufacturing Excellence at Enhanced Speed, Reduced Cost and Superior Quality The 3rd Biologics Manufacturing Asia 2016 will be a focused knowledge sharing platform for Asia’s bioprocessing industry. This event aims to bring together key biopharma and bioprocessing players from Korea, China, Taiwan, India, Japan, Singapore as well as international biopharma and bioprocessing leaders, innovative biotechs, solution providers, contract manufacturing organisations and technocrats to convene on the best manufacturing/bioprocessing practices in order to have access to faster, cheaper and better biologic drugs. Biologics Manufacturing Asia 2016 aims to bring together the key players along the biologics production value at the BIOMANUFACTURING HUB OF ASIA – SINGAPORE. You will be able to acquire actionable inputs from 30+ key opinion leaders on best bio-manufacturing practices, gain critical insights from panel discussions featuring the industry’s foremost experts, driven by quest... Read more

Biomanufacturing Excellence at Enhanced Speed, Reduced Cost and Superior Quality The 3rd Biologics Manufacturing Asia 2016 will be a focused knowledge sharing platform for Asia’s bioprocessing industry. This event aims to bring together key biopharma and bioprocessing players from Korea, China, Taiwan, India, Japan, Singapore as well as international biopharma and bioprocessing leaders, innovative biotechs, solution providers, contract manufacturing organisations and technocrats to convene on the best manufacturing/bioprocessing practices in order to have access to faster, cheaper and better biologic drugs. Biologics Manufacturing Asia 2016 aims to bring together the key players along the biologics production value at the BIOMANUFACTURING HUB OF ASIA – SINGAPORE. You will be able to acquire actionable inputs from 30+ key opinion leaders on best bio-manufacturing practices, gain critical insights from panel discussions featuring the industry’s foremost experts, driven by questions from the audience to ensure that the key challenges facing the sector are examined in detail and build relationships with 250+ industry leaders, decision makers, key members of the bioprocessing community.